HOME


HIV/AIDS HOTLINES


HIV BASICS


POSITIVE PROFILES


ASO SPOTLIGHT


RECENT ARTICLES


HOW TO PAY FOR HIV TREATMENT


ADAP CRITERIA AND FORMULARIES


ASO LISTINGS


REVIEW OF HIV MEDICATIONS


2008 HIV/AIDS FUNDRAISING ACTIVITIES & EVENTS


ABOUT HIV POSITIVE! MAGAZINE


LINKS


SUBSCRIBE


CONTACT US


ADVERTISER INFORMATION

Integrase Inhibitor

Isentress

(Raltegravir)

Manufacturer: Merck

The standard dose of Isentress is one 400 mg tablet taken twice a day. It can be taken without regard to food.

Evaluation: Isentress is a new drug, approved by the FDA in October, 2007. It is the first of a new class of drugs called "integrase inhibitors" which work by blocking a viral enzyme that helps HIV integrate with healthy cell DNA. It is currently approved only for experienced patients who are resistant to multiple HIV drugs.




Combination Drugs

Protease Inhibitors

Nucleoside Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors

Fusion Inhibitor

Entry Inhibitor

Integrase Inhibitor









Copyright 2008, Positive Health Publications, Inc.

This magazine is intended to enhance your relationship with your doctor - not replace it! Medical treatments and products should always be discussed with a licensed physician who has experience treating HIV and AIDS!

::: Made with CoffeeCup : Web Design Software & Website Hosting :::